Calls Now Open
2027 Scholar-Innovator and ADDF-Harrington

May 06, 2026
Benefiting patients worldwide, funding accelerates chronic lymphocytic leukemia research and rare cancer drug development through the Oxford-Harrington Rare Disease Centre and UH Seidman Cancer Center CLEVELAND, Ohio, U.S. and OXFORD, U.K. – University Hospitals (UH) has received $12.5 million in transformational...
Continue Reading
April 16, 2026
In a new episode of the podcast, , welcomes , and , for a conversation on how immune biology is transforming the field of neuroscience and accelerating the path from discovery to patient care.Dr. Anderson, Investigator at Harrington Discovery Institute and Co-Director of the —a partnership between the University of Oxford... Continue Reading
August 22, 2023
A Conversation with Jonathan S. Stamler, MD, President of Harrington Discovery Institute Continue Reading